Product Information
HEPARIN SODIUM 20,000 UNIT/ML VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $7.6218 per ML under NDC 63323091513. Its NADAC has been published 74 times since Feb 19, 2025.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AP.
Strength
20000 [USP'U]/mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323091513
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Effective Date
7/23/2025
Active Ingredients
HEPARIN SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA017029FDA Approved
Before 1982
TE Code
AP
On Market Since
2/22/1972
Pharmacological Classes
Price Statistics
The NADAC for HEPARIN SODIUM 20,000 UNIT/ML VIAL has been published 74 times since Feb 19, 2025, and over the history we have for it it has declined 9.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.6218 per ML |
|---|---|
| All-time high | $8.4366 (Apr 16, 2025) |
| All-time low | $7.6218 (Jun 18, 2025) |
| 52-week high | $7.6218 |
| 52-week low | $7.6218 |
| Median price | $7.6218 |
| Average price | $7.7650 |
| Largest weekly change | -3.4% (Jun 18, 2025) |
| Weeks tracked | 74 |
| Tracking since | Feb 19, 2025 |
1W
N/A
1M
N/A
3M
0.0%
6M
0.0%
1Y
0.0%
3Y
N/A
5Y
N/A
All
-9.7%
Last surveyed Jul 15, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the HEPARIN SODIUM market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Fresenius Kabi USA, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
HEPARIN SODIUM market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-coagulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HEPARIN SODIUM 20,000 UNIT/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for HEPARIN SODIUM 20,000 UNIT/ML VIAL, manufactured by Fresenius Kabi USA, LLC, is $7.6218 per ML (NDC 63323091513), effective Jul 15, 2026.
How has the price of HEPARIN SODIUM 20,000 UNIT/ML VIAL changed over time?
Over the history we have for it, the NADAC for HEPARIN SODIUM 20,000 UNIT/ML VIAL has declined 9.7%. It has been tracked across 74 weekly CMS publications since Feb 19, 2025.
What are the highest and lowest recorded NADAC prices for HEPARIN SODIUM 20,000 UNIT/ML VIAL?
Since Feb 19, 2025, the NADAC for HEPARIN SODIUM 20,000 UNIT/ML VIAL has ranged from a low of $7.6218 (Jun 18, 2025) to a high of $8.4366 (Apr 16, 2025), with a median of $7.6218 per ML.
Are there cheaper alternatives to HEPARIN SODIUM 20,000 UNIT/ML VIAL?
No other NADAC-published product currently shares the active ingredient and strength of HEPARIN SODIUM 20,000 UNIT/ML VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HEPARIN SODIUM 20,000 UNIT/ML VIAL?
HEPARIN SODIUM 20,000 UNIT/ML VIAL (NDC 63323091513) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.